energy

US natural gas futures ended higher as forecasts shifted to show hotter weather in the coming weeks, signaling increased demand for the power-plant fuel as homes and businesses crank up air-conditioners. Intraday and end-of-day settlement prices for the front-month contract reached more than $3 per

To mitigate future energy crises, the world needs more than its current patchwork approach. It needs to build a globally coordinated framework. The post A connected threat needs a connected framework appeared first on Atlantic Council.

Batteries powered by lithium are the undisputed king of the global energy transition. But in a farsighted move to hedge against growing resource nationalism and diversify its offerings, Contemporary Amperex Technology Co. is putting money on creating a new supply chain and commercializing a rival sy

NextEra Energy Inc.’s $67 billion bid for Dominion Energy Inc. won’t just create an energy giant stretching from Florida to Virginia, it’s also helping the power firm shore up its credit standing in the eyes of rating companies.

To mitigate future energy crises, the world needs more than its current patchwork approach. It needs to build a globally coordinated framework. The post A connected threat needs a connected framework appeared first on Atlantic Council.

Stock Market Today: Dow Weakens As Oil Swings Higher; These Warren Buffett New Names Rise (Live Coverage)

Evercore’s Roger Altman said in a CNBC interview on Monday that a sharp rise in crude could destabilize markets before it may trigger “the second big inflation shock of this decade after COVID,” especially if oil prices climb toward $150 a barrel or higher.

Ford just inked a deal with a French electric-utility company.

Invesco SteelPath MLP & Energy Infrastructure ETF declares monthly distribution of $0.1000

SOUTH SAN FRANCISCO, Calif., May 18, 2026 (GLOBE NEWSWIRE) -- Quince Therapeutics, Inc. (Nasdaq: QNCX) announced it has acquired Orphai Therapeutics Inc., a clinical-stage biotechnology company. The acquisition brings Orphai’s lead program LAM-001, an inhaled formulation of rapamycin (mTOR inhibitor